- Systematic Review
Rapamycin’s Impact on Age-Related Macular Degeneration—A Systematic Review and Hormesis Perspective
- Knut Sandok Wigestrand,
- Santosh Gupta,
- Kulbhushan Sharma and
- Goran Petrovski
17 September 2024
Background: Pre-clinical studies related to the use of rapamycin (Sirolimus®), a mammalian target of rapamycin (mTOR) inhibitors, for age-related macular degeneration (AMD) have shown improved therapeutic outcomes. However, knowledge of its dose&...

